Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Oct;113(2):349–354. doi: 10.1111/j.1476-5381.1994.tb16994.x

Blockade of P2X-purinoceptors by trypan blue in rat vas deferens.

R Bültmann 1, M Trendelenburg 1, K Starke 1
PMCID: PMC1510092  PMID: 7834182

Abstract

1. The possibility of an antagonist effect of trypan blue at P2X-purinoceptors was studied in rat vas deferens. 2. Trypan blue (3.2-320 microM) shifted the concentration-contraction response curve of alpha,beta-methylene ATP (alpha,beta-MeATP) to the right and simultaneously increased the maximum of the curve by up to 40%. The Schild plot had a slope not significantly different from unity and yielded a pA2 value of 5.3 (KB 4.9 microM). 3. Suramin (32 microM) also shifted the concentration-response curve of alpha,beta-MeATP to the right, KB 2.6 microM, and increased the maximum by 31%. In the presence of suramin (32 microM), trypan blue (32 microM) did not change the concentration-response curve of alpha,beta-MeATP. 4. 1-Amino-8-naphthol-3, 6-disulphonate (H-acid) 10 mM, the sulphonic acid-carrying moiety of trypan blue, shifted the concentration-response curve of alpha,beta-MeATP to the right, KB 1.4 mM, and increased the maximum by 33%. 5. Trypan blue did not change contractions elicited by high K+ and noradrenaline. 6. Trypan blue attenuated the purinergic component of neurogenic contractions, IC50 44.9 microM, but did not change the adrenergic component. 7. It is concluded that trypan blue blocks P2X-purinoceptors in rat vas deferens. The increase of the maximum of the alpha,beta-MeATP concentration-response curve is similar in mechanism to the increase produced by suramin.

Full text

PDF
349

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blakeley A. G., Brockbank J. E., Kelly S. S., Petersen S. A. Effects of suramin on the concentration--response relationship of alpha, beta-methylene ATP on the mouse vas deferens. J Auton Pharmacol. 1991 Feb;11(1):45–49. doi: 10.1111/j.1474-8673.1991.tb00243.x. [DOI] [PubMed] [Google Scholar]
  3. Boland B., Himpens B., Vincent M. F., Gillis J. M., Casteels R. ATP activates P2x-contracting and P2y-relaxing purinoceptors in the smooth muscle of mouse vas deferens. Br J Pharmacol. 1992 Dec;107(4):1152–1158. doi: 10.1111/j.1476-5381.1992.tb13422.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bültmann R., Starke K. Evans blue blocks P2X-purinoceptors in rat vas deferens. Naunyn Schmiedebergs Arch Pharmacol. 1993 Dec;348(6):684–687. doi: 10.1007/BF00167248. [DOI] [PubMed] [Google Scholar]
  5. Bültmann R., Starke K. P2-purinoceptor antagonists discriminate three contraction-mediating receptors for ATP in rat vas deferens. Naunyn Schmiedebergs Arch Pharmacol. 1994 Jan;349(1):74–80. doi: 10.1007/BF00178209. [DOI] [PubMed] [Google Scholar]
  6. Bültmann R., Szabo B., Starke K. Inhibition by ethanol of contractions of rat vas deferens: no evidence for selective blockade of P2X-purinoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1993 May;347(5):527–533. doi: 10.1007/BF00166746. [DOI] [PubMed] [Google Scholar]
  7. Dunn P. M., Blakeley A. G. Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens. Br J Pharmacol. 1988 Feb;93(2):243–245. doi: 10.1111/j.1476-5381.1988.tb11427.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fuder H., Muth U. ATP and endogenous agonists inhibit evoked [3H]-noradrenaline release in rat iris via A1 and P2y-like purinoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1993 Oct;348(4):352–357. doi: 10.1007/BF00171333. [DOI] [PubMed] [Google Scholar]
  9. Hoyle C. H., Knight G. E., Burnstock G. Suramin antagonizes responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli. Br J Pharmacol. 1990 Mar;99(3):617–621. doi: 10.1111/j.1476-5381.1990.tb12979.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kennedy C. P1- and P2-purinoceptor subtypes--an update. Arch Int Pharmacodyn Ther. 1990 Jan-Feb;303:30–50. [PubMed] [Google Scholar]
  11. Lambrecht G., Friebe T., Grimm U., Windscheif U., Bungardt E., Hildebrandt C., Bäumert H. G., Spatz-Kümbel G., Mutschler E. PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses. Eur J Pharmacol. 1992 Jul 7;217(2-3):217–219. doi: 10.1016/0014-2999(92)90877-7. [DOI] [PubMed] [Google Scholar]
  12. Leff P., Wood B. E., O'Connor S. E. Suramin is a slowly-equilibrating but competitive antagonist at P2x-receptors in the rabbit isolated ear artery. Br J Pharmacol. 1990 Nov;101(3):645–649. doi: 10.1111/j.1476-5381.1990.tb14134.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mallard N., Marshall R., Sithers A., Spriggs B. Suramin: a selective inhibitor of purinergic neurotransmission in the rat isolated vas deferens. Eur J Pharmacol. 1992 Sep 10;220(1):1–10. doi: 10.1016/0014-2999(92)90004-n. [DOI] [PubMed] [Google Scholar]
  14. McMillian M. K., Soltoff S. P., Lechleiter J. D., Cantley L. C., Talamo B. R. Extracellular ATP increases free cytosolic calcium in rat parotid acinar cells. Differences from phospholipase C-linked receptor agonists. Biochem J. 1988 Oct 1;255(1):291–300. [PMC free article] [PubMed] [Google Scholar]
  15. Motulsky H. J., Ransnas L. A. Fitting curves to data using nonlinear regression: a practical and nonmathematical review. FASEB J. 1987 Nov;1(5):365–374. [PubMed] [Google Scholar]
  16. Soltoff S. P., McMillian M. K., Talamo B. R., Cantley L. C. Blockade of ATP binding site of P2 purinoceptors in rat parotid acinar cells by isothiocyanate compounds. Biochem Pharmacol. 1993 May 5;45(9):1936–1940. doi: 10.1016/0006-2952(93)90455-6. [DOI] [PubMed] [Google Scholar]
  17. Soltoff S. P., McMillian M. K., Talamo B. R. Coomassie Brilliant Blue G is a more potent antagonist of P2 purinergic responses than Reactive Blue 2 (Cibacron Blue 3GA) in rat parotid acinar cells. Biochem Biophys Res Commun. 1989 Dec 29;165(3):1279–1285. doi: 10.1016/0006-291x(89)92741-1. [DOI] [PubMed] [Google Scholar]
  18. Trezise D. J., Kennedy I., Humphrey P. P. Characterization of purinoceptors mediating depolarization of rat isolated vagus nerve. Br J Pharmacol. 1993 Nov;110(3):1055–1060. doi: 10.1111/j.1476-5381.1993.tb13920.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Venkova K., Krier J. Stimulation of lumbar sympathetic nerves evokes contractions of cat colon circular muscle mediated by ATP and noradrenaline. Br J Pharmacol. 1993 Nov;110(3):1260–1270. doi: 10.1111/j.1476-5381.1993.tb13951.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ziganshin A. U., Hoyle C. H., Bo X., Lambrecht G., Mutschler E., Bäumert H. G., Burnstock G. PPADS selectively antagonizes P2X-purinoceptor-mediated responses in the rabbit urinary bladder. Br J Pharmacol. 1993 Dec;110(4):1491–1495. doi: 10.1111/j.1476-5381.1993.tb13990.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. von Kügelgen I., Bültmann R., Starke K. Interaction of adenine nucleotides, UTP and suramin in mouse vas deferens: suramin-sensitive and suramin-insensitive components in the contractile effect of ATP. Naunyn Schmiedebergs Arch Pharmacol. 1990 Aug;342(2):198–205. doi: 10.1007/BF00166965. [DOI] [PubMed] [Google Scholar]
  22. von Kügelgen I., Kurz K., Starke K. P2-purinoceptor-mediated autoinhibition of sympathetic transmitter release in mouse and rat vas deferens. Naunyn Schmiedebergs Arch Pharmacol. 1994 Feb;349(2):125–132. doi: 10.1007/BF00169828. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES